Litcius/Paper detail

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

Changhoon Yoo, Kyu‐pyo Kim, Jae Ho Jeong, Il Hwan Kim, Myoung Joo Kang, Jaekyung Cheon, Byung Woog Kang, Hyewon Ryu, Ji Sung Lee, Kyung Won Kim, Ghassan K. Abou‐Alfa, Baek‐Yeol Ryoo

2021The Lancet Oncology220 citationsDOI

Topics & Concepts

GemcitabineMedicineIrinotecanClinical endpointFluorouracilInternal medicinePhases of clinical researchCisplatinOncologyGastroenterologyColorectal cancerChemotherapySurgeryCancerClinical trialCholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and PrognosisGallbladder and Bile Duct Disorders